Kros JM - Search Results

1

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome.

Kros JM, Gorlia T, Kouwenhoven MC, Zheng PP, Collins VP, Figarella-Branger D, Giangaspero F, Giannini C, Mokhtari K, Mørk SJ, Paetau A, Reifenberger G, van den Bent MJ. Kros JM, et al. J Neuropathol Exp Neurol. 2007 Jun;66(6):545-51. doi: 10.1097/01.jnen.0000263869.84188.72. J Neuropathol Exp Neurol. 2007. PMID: 17549014 Clinical Trial.

2

Ultrastructural characterization of transitional cells in oligodendrogliomas.

Kros JM, de Jong AA, van der Kwast TH. Kros JM, et al. J Neuropathol Exp Neurol. 1992 Mar;51(2):186-93. doi: 10.1097/00005072-199203000-00008. J Neuropathol Exp Neurol. 1992. PMID: 1538242

3

Prognostic relevance of DNA flow cytometry in oligodendroglioma.

Kros JM, van Eden CG, Vissers CJ, Mulder AH, van der Kwast TH. Kros JM, et al. Cancer. 1992 Apr 1;69(7):1791-8. doi: 10.1002/1097-0142(19920401)69:7<1791::aid-cncr2820690722>3.0.co;2-z. Cancer. 1992. PMID: 1551064

4

Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.

Rosso SM, van Dekken H, Krishnadath KK, Alers JC, Kros JM. Rosso SM, et al. Among authors: kros jm. J Neuropathol Exp Neurol. 1997 Oct;56(10):1125-31. doi: 10.1097/00005072-199710000-00006. J Neuropathol Exp Neurol. 1997. PMID: 9329456

5

The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.

Straathof CS, van den Bent MJ, Ma J, Schmitz PI, Kros JM, Stoter G, Vecht CJ, Schellens JH. Straathof CS, et al. Among authors: kros jm. J Neurooncol. 1998 Mar;37(1):1-8. doi: 10.1023/a:1005835212246. J Neurooncol. 1998. PMID: 9525832

6

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HG, Taphoorn MJ, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJ, Boogerd W. van den Bent MJ, et al. Among authors: kros jm. Neurology. 1998 Oct;51(4):1140-5. doi: 10.1212/wnl.51.4.1140. Neurology. 1998. PMID: 9781544

7

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

van den Bent MJ, Schellens JH, Vecht CJ, Sillevis Smit PA, Loosveld OJ, Ma J, Tijssen CC, Jansen RL, Kros JM, Verweij J. van den Bent MJ, et al. Among authors: kros jm. Eur J Cancer. 1998 Sep;34(10):1570-4. doi: 10.1016/s0959-8049(98)00138-5. Eur J Cancer. 1998. PMID: 9893630 Clinical Trial.

8

Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.

Luider TM, Kros JM, Sillevis Smitt PA, van den Bent MJ, Vecht CJ. Luider TM, et al. Among authors: kros jm. Electrophoresis. 1999 Apr-May;20(4-5):1087-91. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<1087::AID-ELPS1087>3.0.CO;2-6. Electrophoresis. 1999. PMID: 10344289

9

Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH).

Kros JM, van Run PR, Alers JC, Beverloo HB, van den Bent MJ, Avezaat CJ, van Dekken H. Kros JM, et al. J Pathol. 1999 Jul;188(3):282-8. doi: 10.1002/(SICI)1096-9896(199907)188:3<282::AID-PATH355>3.0.CO;2-S. J Pathol. 1999. PMID: 10419597

10

Cytogenetic analysis of gemistocytic cells in gliomas.

Kros JM, Waarsenburg N, Hayes DP, Hop WC, van Dekken H. Kros JM, et al. J Neuropathol Exp Neurol. 2000 Aug;59(8):679-86. doi: 10.1093/jnen/59.8.679. J Neuropathol Exp Neurol. 2000. PMID: 10952058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page